# 4 Animals AlsterScience

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/4-animals-alsterscience

- Industry: Biotechnology
- Headquarters: Hamburg, Germany
- Website: www.alsterscience.com
- Latest round: Seed (Oct 9, 2014)
- Investors on record: 2

## About

4 Animals AlsterScience GmbH develops innovative immunological solutions to enhance animal health, focusing on disease prevention and therapy linked to the immune system.4 Animals AlsterScience GmbH is focused on developing products aimed at improving animal health, specifically through innovative immunological solutions. The company is headquartered in Hamburg, Germany. In October 2014, it secured financing from High-Tech Gründerfonds and Innovationsstarter Fonds Hamburg, although specific financial details were not disclosed. The company has engaged in a single investment deal to date. The founder has not been specified in the available information.AlsterScience GmbH specializes in innovative immunological solutions aimed at enhancing the health of animals, particularly in the prevention and therapy of various diseases linked to the immune system. Their core offerings include biological pharmaceuticals that support immune system functions, specifically designed to combat infections, tumor diseases, and other health issues exacerbated by stress, malnutrition, aging, and vaccination failures. These products target a diverse clientele, including veterinarians, animal health professionals, and pet owners, with a focus on improving the overall well-being of animals, particularly horses and companion pets. AlsterScience’s solutions are distributed across multiple geographical markets, with a notable presence in Europe and other regions where animal health and welfare are prioritized.AlsterScience GmbH generates revenue through direct sales of its immunological products to veterinary clinics and animal health retailers, establishing a structure that supports both B2B transactions and direct-to-consumer sales. The company’s flagship products are positioned in a premium pricing segment, reflecting their advanced approach to animal health care. Transactions are typically structured around product purchases where veterinary practices and retailers order in bulk to meet the demands of their clients. This model allows for consistent revenue streams as veterinary practices seek reliable and effective treatments to enhance animal health. Specific pricing details for individual products have not been disclosed, indicating a focus on tailored solutions for specific client needs.Looking forward, AlsterScience GmbH plans to design and launch new immunological products, with timelines to be determined as development progresses. The company aims to expand into additional markets, particularly in regions where demand for innovative animal health solutions is increasing. The funding acquired in October 2014 will be utilized to support these future initiatives and enhance product development efforts.

## Funding rounds

- Seed, Oct 9, 2014 — High-Tech Gruenderfonds, Innovationsstarter Fonds Hamburg

## Investors

- High-Tech Gruenderfonds (https://capitalatlas.ai/funds/high-tech-gruenderfonds) — Seed
- Innovationsstarter Fonds Hamburg (https://capitalatlas.ai/funds/innovationsstarter-fonds-hamburg) — Seed